Skip to content

Add on effect of Punarnavadi eye drops alone and along with Haridra khanda in the management of Conjunctivitis.

The add on effect of haridra khanda along with punarnavadi eye drops in the management of abhishyanda -allergic conjunctivitis- an open label double arm randomized control clinical trial. - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/068963
Enrollment
72
Registered
2024-06-14
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: H109- Unspecified conjunctivitis

Interventions

None listed

Sponsors

AII India Institute Of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria- 1.Patients presenting with signs and symptoms of Abhishyanda (Allergic conjunctivitis, vernal keratoconjunctivitis/spring catarrh). 2.Between the age group of 12-40 years. 3.Patients willing for trial and follow up.

Exclusion criteria

Exclusion criteria: Exclusion criteria- 1.Patients having viral and bacterial conjunctivitis. 2.Patients suffering from Atopic keratoconjunctivitis, Giant papillary conjunctivitis, phlyctenular keratoconjunctivitis. 3.Patients having complicated eye diseases and trachoma, chalazion, stye, pterygium, dacryocystitis, trichiasis etc. 4.Patients suffering from corneal opacity, ulcers. 5.Patients suffering from major systemic illness necessitating long term treatment. 6.patient using antihistaminics drugs.

Design outcomes

Primary

MeasureTime frame
Improvement in symptoms of Abhishyanda (allergic conjunctivitis) like Kandu(itching) Achchhaashruta ( watery discharge). Timepoint: Oth day, 14th day, 28th day, 42nd day

Secondary

MeasureTime frame
1.Improvement in remaining signs & symptoms like Stambana, Shirobhitaapa, Alpshophta, Parushya, Sangharsha. 2.Improvement in the Absolute eosinophil count, IgE. 3.To see the changes in Conjunctival Smear test. 4.Improvement in the Impression Cytology (If Possible)- Minimum 6 patients in each group. Timepoint: 42 days

Countries

India

Contacts

Public Contactvibha kulhari

ALLINDIA INSTITUTE OF AYURVEDA

bhatrajma2008@gmail.com9560788850

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026